Top compounds associated with response to PRDM11


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC 0.14 0.008
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.12 0.008
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.093 0.009
mRNA Vandetanib CCLE pan-cancer AAC 0.13 0.009
mRNA PD173074 GDSC1000 pan-cancer AAC -0.087 0.01
mRNA momelotinib CTRPv2 pan-cancer AAC 0.088 0.01
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.01
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.086 0.01
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.02
Download CSV